Comunicação curta
Pancreatic Cancer Remains a Deadly Disease. Why?
Avaliação especializada
Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas
Comentário
Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)
Hipótese
Clinical Presentations of Rare Pancreatic Neuroendocrine Neoplasms (panNENs)
Artigo original
Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis
Does stenting of pancreaticojejunostomy after pancreatico-duodenectomy mitigate expected complication - Evaluation of a prospective observational study.